In this way, the varied expression patterns of C-Myc and Ki-67 can be used to cross-reference KA and cSCC during the clinical diagnosis process, although further research with increased sample sizes will be required to substantiate these speculations. This evidence concerns the gene MKI67 and skin squamous cell carcinoma.